Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 129))

Abstract

Soon after the development of binding assays using [3H]5-hydroxytryptamine ([3H]5-HT) to label the specific recognition sites for serotonin on membranebound receptors in the central nervous system (CNS), differences from one brain area to another were noted which suggested the existence of several distinct classes of binding sites. In particular, comparison of the fate of [3H]5- HT high-affinity binding sites in the rat brain after the selective degeneration of serotoninergic neurones due to the intra-raphe infusion of the neurotoxin 5,7-dihydroxytryptamine (5,7-DHT) showed that both the hippocampal and striatal sites are located on postsynaptic targets of serotoninergic projections (Nelson et al. 1978), where they are subjected, however, to differential adaptive changes after the lesion. Thus a significant increase in the density of [3H]5-HT high-affinity binding sites was noted in the hippocampus but not in the striatum (Nelson et al. 1978). Studies of the pharmacological properties of [3H]5-HT high-affinity binding also revealed that the radioactive indoleamine probably recognises several distinct high-affinity sites in brain membranes. Indeed, inhibition of [3H]5-HT high-affinity binding by drugs such as methiothepin and quipazine yielded (apparent) Hill coefficients of less than 1.0, as expected of the heterogeneity of corresponding binding sites (Nelson et al. 1978).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

eBook
GBP 9.99
Price includes VAT (United Kingdom)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
GBP 44.99
Price includes VAT (United Kingdom)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Aghajanian GK, Lakoski JM (1984) Hyperpolarization of serotonergic neurons by serotonin and LSD: studies in brain slices showing increased K+ conductance. Brain Res 305: 181–185

    Article  PubMed  CAS  Google Scholar 

  • Ahlenius S, Larsson K, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wikström H, Sanchez D, Arvidsson L-E, Hacksell U, Nilsson JLG (1981) Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav 15: 785–792

    Article  PubMed  CAS  Google Scholar 

  • Ahlenius S, Larsson K, Wijkström A (1991) Behavioral and biochemical effects of the 5-HT1A receptor agonists flesinoxan and 8-OH-DPAT in the rat. Eur J Pharmacol 200: 259–266

    Article  PubMed  CAS  Google Scholar 

  • Albert PR, Zhou QY, Van Tol HH, Bunzow JR, Civelli O (1990) Cloning, functional expression and mRNA tissue distribution of the rat 5-HT1A receptor gene. J Biol Chem 265: 5825–5832

    PubMed  CAS  Google Scholar 

  • Arnone M, Baroni M, Gai J, Guzzi U, Desclaux MF, Keane PE, Le Fur G, Soubrié P (1995) Effect of SR 59026A, a new 5-HT1A receptor agonist, on sexual activity in male rats. Behav Pharmacol 6: 276–282

    Article  PubMed  CAS  Google Scholar 

  • Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of patients with depression treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51: 248–251

    Article  PubMed  CAS  Google Scholar 

  • Baldwin DS (1996) Depression and sexual function. J Psychopharmacol 10 [Suppl 1]: 30–34

    Google Scholar 

  • Beck SG, Choi KC, List TJ (1992) Comparison of 5-hydroxytryptamine1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther 263: 350–359

    PubMed  CAS  Google Scholar 

  • Besse D, Lombard MC, Zajac JM, Roques B, Besson JM (1990) Pre- and postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the dorsal horn of the rat spinal cord. Brain Res 521: 15–22

    Article  PubMed  CAS  Google Scholar 

  • Bjork L, Cornfield LJ, Nelson DL, Hillver S-E, Anden N-E, Lewander T, Hacksell U (1991) Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8- hydroxy-2-(dipropylamino)tetralin-induced effects. J Pharmacol Exp Ther 258: 58–65

    PubMed  CAS  Google Scholar 

  • Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15: 217–222

    Article  PubMed  CAS  Google Scholar 

  • Blier P, De Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15: 220–226

    Article  PubMed  CAS  Google Scholar 

  • Boddeke HWGM, Fargin A, Raymond JR, Schoeffter P, Hoyer D (1992) Agonist/ antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells. Naunyn-Schmiedebergs Arch Pharmacol 345: 257–263

    PubMed  CAS  Google Scholar 

  • Bode-Greuel KM, Klisch J, Glaser T, Traber J (1990) Serotonin(5-HT)1A receptor agonists as neuroprotective agents in cerebral ischemia, In: Krieglstein J, Oberpichler H (eds) Pharmacology of cerebral ischemia. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 485–491

    Google Scholar 

  • Boess FG, Martin JL (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33: 275–317

    Article  PubMed  CAS  Google Scholar 

  • Bolaños FJ, Schechter LE, Laporte AM, Hamon M, Gozlan H (1991) Recovery of 5-HT1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2- dihydroquinoline (EEDQ). Proc West Pharmacol Soc 34: 387–393

    PubMed  Google Scholar 

  • Boni C, Fabre V, Lima L, Martres MP, Hamon M (1996) Transient increase in brain 5- HT1A receptor mRN A levels after EEDQ-induced irreversible blockade of 5-HT1A receptors. J Neurochem 66 [Suppl 2]: S36A

    Google Scholar 

  • Burnet PWJ, Mefford IN, Smith CC, Gold PW, Sternberg EM (1992) Hippocampal [3H]8-hydroxy-2-(di~n-propylamino)tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamo-pituitary-adrenal axis in rat. J Neurochem 59: 1062–1070

    Article  PubMed  CAS  Google Scholar 

  • Chanda PK, Minchin MCW, Davis AR, Greenberg L, Reilly Y, McGregor WH, Bhat R, Lubeck MD, Mizutani S, Hung PP (1993) Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor. Mol Pharmacol 43: 516–520

    PubMed  CAS  Google Scholar 

  • Charrier D, Dangoumau L, Hamon M, Puech AJ, Thiébot MH (1994) Effects of 5- HT1A receptor ligands on a safety signal withdrawal procedure of conflict in the rat. Pharmacol Biochem Behav 48: 281–289

    Article  PubMed  CAS  Google Scholar 

  • Cliffe IA, Fletcher A, Dourish CT (1993) The evolution of selective, silent 5-HT1A receptor antagonists. Current Drugs Ltd ISSN 0961-4680, pp 1–25

    Google Scholar 

  • Claustre Y, Rouquier L, Serrano A, Bénavidès J, Scatton B (1991) Effect of the putative 5-HT1A receptor antagonist NAN-190 on rat brain serotonergic transmission. Eur J Pharmacol 204: 71–77

    Article  PubMed  CAS  Google Scholar 

  • Corradetti R, Le Poul E, Laaris N, Hamon M, Lanfumey L (1996) Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotoninergic neurons and CA1 hippocampal pyramidal cells in vitro. J Pharmacol Exp Ther 278: 679–688

    PubMed  CAS  Google Scholar 

  • Cossery JM, Gozlan H, Spampinato U, Perdicakis C, Guillaumet G, Pichat L, Hamon M (1987) The selective labelling of central 5-HT1A receptor binding sites by [3H]5- methoxy-3-(di-n-propylamino)chroman. Eur J Pharmacol 140: 143–155

    Article  PubMed  CAS  Google Scholar 

  • Daval G, Vergé D, Basbaum AI, Bourgoin S, Hamon M (1987a) Autoradiographic evidence of serotonin1, binding sites on primary afferent fibres in the dorsal horn of the rat spinal cord. Neurosci Lett 83: 71–76

    Article  PubMed  CAS  Google Scholar 

  • Daval G, Vergé D, Becerril A, Gozlan H, Spampinato U, Hamon M (1987b) Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development. Int J Devl Neurosci 5: 171–180

    Article  CAS  Google Scholar 

  • Detlke MJ, Wieland S, Lucki I (1995) Blockade of the antidepressant-like effects of 8- OH-DPAT, buspirone and desipramine in the rat forced swim test by 5-HT1A receptor antagonists. Psychopharmacology 119: 47–54

    Article  Google Scholar 

  • De Vitry F, Hamon M, Catelon J, Dubois M, Thibault J (1986) Serotonin initiates and autoamplifies its own synthesis during mouse central nervous system development. Proc Natl Acad Sci USA 83: 8629–8633

    Article  PubMed  Google Scholar 

  • El Mestikawy S, Taussig D, Gozlan H, Emerit MB, Ponchant M, Hamon M (1989) Chromatographic analyses of the serotonin 5-HT1A receptor solubilized from the rat hippocampus. J Neurochem 53: 1555–1566

    Article  PubMed  CAS  Google Scholar 

  • El Mestikawy S, Riad M, Laporte AM, Vergé D, Daval G, Gozlan H, Hamon M (1990) Production of specific anti-rat 5-HT1A receptor antibodies in rabbits injected with a synthetic peptide. Neurosci Lett 118: 189–192

    Article  PubMed  CAS  Google Scholar 

  • Emerit MB, El Mestikawy S, Gozlan H, Rouot B, Hamon M (1990) Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins. Biochem Pharmacol 39: 7–18

    Article  PubMed  CAS  Google Scholar 

  • Engleman EA, Robertson DW, Thompson DC, Perry KW, Wong DT (1996) Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus. J Neurochem 66: 599–603

    Article  PubMed  CAS  Google Scholar 

  • Fargin A, Raymond JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ (1988) The genomic clone G-21 which resembles a ß-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 335: 358–360

    Article  PubMed  CAS  Google Scholar 

  • Fargin A, Raymond JR, Regan JW, Cotecchia S, Lefkowitz RJ, Caron MG (1989) Effector coupling mechanisms of the cloned 5-HT1A receptor. J Biol Chem 264: 14848–14852

    PubMed  CAS  Google Scholar 

  • File SE, Gonzalez LE, Andrews N (1996) Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests. J Neurosci 16: 4810–4815

    PubMed  CAS  Google Scholar 

  • Fletcher A, Bill DJ, Bill SJ, Cliffe IA, Dover GM, Forster EA, Haskins TJ, Jones D, Mansell HL, Reilly Y (1993) WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors. Eur J Pharmacol 237: 283–291

    Article  PubMed  CAS  Google Scholar 

  • Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJP, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M, Dourish CT (1996) Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent selective, and silent 5-HT1A receptor antagonist. Behav Brain Res 73: 337–353

    Article  PubMed  CAS  Google Scholar 

  • Fornal CA, Marrosu F, Metzler CW, Tada K, Jacobs BL (1994a) Effects of the putative 5-hydroxytryptamine1A antagonists BMY 7378, NAN 190 and (-)-propranolol on serotonergic dorsal raphe unit activity in behaving cats. J Pharmacol Exp Ther 270: 1359–1366

    PubMed  CAS  Google Scholar 

  • Fornal CA, Metzler CW, Gallegos R, Veasey SC, McCreary A, Jacobs BL (1994b) WAY-100635, a potent and selective 5-HT1A receptor antagonist, increases serotonergic neuronal activity and blocks the action of 8-OH-DPAT in behaving cats. Soc Neurosci 20: 1544

    Google Scholar 

  • Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A (1995) A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY- 100635. Eur J Pharmacol 281: 81–88

    Article  PubMed  CAS  Google Scholar 

  • Fournier J, Steinberg R, Gauthier T, Keane PE, Guzzi U, Coudé FX, Bougault I, Maffrand JP, Soubrié P, Le Fur G (1993) Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates. Neuroscience 55: 629–641

    Article  PubMed  CAS  Google Scholar 

  • Gardier AM, Malagié I, Trillat AC, Jacquot C, Artigas F (1996) Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam Clin Pharmacol 10: 16–27

    Article  PubMed  CAS  Google Scholar 

  • Gartside SE, Cowen PJ, Hjorth S (1990) Effects of MDL 73005EF on central pre-and postsynaptic 5-HT1A receptor function in the rat in vivo. Eur J Pharmacol 191: 391–400

    Article  PubMed  CAS  Google Scholar 

  • Gérard C, Langlois X, Gingrich J, Doucet E, Vergé D, Kia HK, Raisman R, Gozlan H, El Mestikawy S, Hamon M (1994) Production and characterization of polyclonal antibodies recognizing the intracytoplasmic third loop of the 5- hydroxytryptamine1A receptor. Neuroscience 62: 721–739

    Article  PubMed  Google Scholar 

  • Glennon RA, Naiman NA, Peirson ME, Titeler M, Lyon RA, Herndon JL, Misenheimer B (1989) NAN-190, a potential 5-HT1A serotonin antagonist. Drug Dev Res 16: 335–343

    Article  CAS  Google Scholar 

  • Gozlan H, El Mestikawy S, Pichat L, Glowinski J, Hamon M (1983) Identification of presynaptic serotonin autoreceptors using a new ligand: [3H]PAT. Nature 305: 140–142

    Article  PubMed  CAS  Google Scholar 

  • Gozlan H, Ponchant M, Daval G, Verge D, Ménard F, Vanhove A, Beaucourt JP, Hamon M (1988) [125I]Bolton-Hunter-8-methoxy-2-[N-propyl-N- propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies. J Pharmacol Exp Ther 244: 751–759

    PubMed  CAS  Google Scholar 

  • Gozlan H, Laporte AM, Thibault S, Schechter LE, Bolaños F, Hamon M (1994) Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Neuropharmacology 33: 423–431

    Article  PubMed  CAS  Google Scholar 

  • Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M (1995) The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptor binding sites in rat brain membranes. Eur J Pharmacol Mol Pharmacol 288: 173–186

    Article  CAS  Google Scholar 

  • Haj-Dahmane S, Hamon M, Lanfumey L (1991) K+ channel and 5- hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: an in vitro electrophysiological study. Neuroscience 41: 495–505

    Article  PubMed  CAS  Google Scholar 

  • Haj-Dahmane S, Jolas T, Laporte AM, Gozlan H, Farré AJ, Hamon M, Lanfumey L (1994) Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat. Eur J Pharmacol 255: 185–196

    Article  PubMed  CAS  Google Scholar 

  • Hall MD, El Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H (1985) [3H]8- hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J Neurochem 44: 1685–1696

    Article  PubMed  CAS  Google Scholar 

  • Hamon M (1994) Neuropharmacology of anxiety: perspectives and prospects. Trends Pharmacol Sci 15: 36–39

    Article  PubMed  CAS  Google Scholar 

  • Hamon M, Bourgoin S, Gozlan H, Hall MD, Goetz C, Artaud F, Horn AS (1984) Biochemical evidence of the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n- propylamino)tetralin) in the rat brain. Eur J Pharmacol 100: 263–276

    Article  PubMed  CAS  Google Scholar 

  • Hamon M, Bourgoin S, Chanez C, De Vitry F (1989) Do serotonin and other neurotransmitters exert a trophic influence on the immature brain? In: Evrard P, Minkowski A (eds) Developmental neurobiology. Raven, New York, pp 171–183

    Google Scholar 

  • Hamon M, Gozlan H, El Mestikawy S, Emerit MB, Bolaños F, Schechter L (1990) The central 5-HT1A receptors: pharmacological, biochemical, functional and regulatory properties. Ann NY Acad Sci 600: 114–131

    Article  PubMed  CAS  Google Scholar 

  • Hillion J, Dumas Milne-Edwards JB, Catelon J, De Vitry F, Gros F, Hamon M (1993) Prenatal developmental expression of rat brain 5-HT1A receptor gene followed by PCR. Biochem Biophys Res Commun 191: 991–997

    Article  PubMed  CAS  Google Scholar 

  • Hillion J, Catelon J, Riad M, Hamon M, De Vitry F (1994) Neuronal localization of 5- HT1A receptor mRNA and protein in rat embryonic brain stem cultures. Devl Brain Res 79: 195–202

    Article  CAS  Google Scholar 

  • Hjorth S (1992) (-)-Penbutolol as a blocker of central 5-HT1A receptor-mediated responses. Eur J Pharmacol 222: 121–127

    Article  PubMed  CAS  Google Scholar 

  • Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikström H, Arvidsson L-E, Hacksell U, Nilsson JLG (1982) 8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity. J Neural Transm 55: 169–188

    Article  CAS  Google Scholar 

  • Hogg S, Andrews N, File SE (1994) Contrasting behavioural effects of 8-OH-DPAT in the dorsal raphe nucleus and ventral hippocampus. Neuropharmacology 33: 343–348

    Article  PubMed  CAS  Google Scholar 

  • Hoyer D, Schoeffter P, Palacios JM, Kalkman HO, Bruinvels AT, Fozard JR, Seigl H, Seiler MP, Stoll A (1992) SDZ 216-525: a selective, potent and silent 5-HT1A receptor antagonist. Br J Pharmacol 105: 29P

    Google Scholar 

  • Hoyer D, Clarke D, Fozard JR, Hartig PR, Martin G, Mylecharane E, Saxena P, Humphrey PPA (1994) VII. International Union of Pharmacology Classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol Rev 46: 157–203

    PubMed  CAS  Google Scholar 

  • Hume SP, Ashworth S, Opacka-Juffry J, Ahier RG, Lammertsma AA, Pike VW, Cliffe IA, Fletcher A, White AC (1994) Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain. Eur J Pharmacol 271: 515–523

    Article  PubMed  CAS  Google Scholar 

  • Hutson PH, Dourish CT, Curzon G (1987) 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)-induced hyperphagia: neurochemical and pharmacological evidence for an involvement of 5-hydroxytryptamine somatodendritic autoreceptors. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors (eds) Ellis Horwood Series in Biomedicine, Chichester, pp 211–232

    Google Scholar 

  • Joëls M, Hesen W, De Kloet ER (1991) Mineralocorticoid hormones suppress serotonin-induced hyperpolarization of rat hippocampal CA1 neurons. J Neurosci 11: 2288–2294

    PubMed  Google Scholar 

  • Jolas T, Haj-Dahmane S, Lanfumey L, Fattaccini CM, Kidd EJ, Adrien J, Gozlan H, Guardiola-Lemaitre B, Hamon M (1993) (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain. Naunyn- Schmiedebergs Arch Pharmacol 347: 453–463

    Article  PubMed  CAS  Google Scholar 

  • Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H, Hamon M (1994) Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J Pharmacol Exp Ther 268: 1432–1443

    PubMed  CAS  Google Scholar 

  • Jolas T, Schreiber R, Laporte AM, Chastanet M, De Vry J, Glaser T, Adrien J, Hamon M (1995) Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5- HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J Pharmacol Exp Ther 272: 920–929

    PubMed  CAS  Google Scholar 

  • Khawaja X (1995) Quantitative autoradiographic characterisation of the binding of [3H]WAY-100635, a selective 5-HT1A receptor antagonist. Brain Res 673: 217–225

    Article  PubMed  CAS  Google Scholar 

  • Kia, HK, Brisorgueil MJ, Hamon M, Calas A, Vergé D (1996a) Ultrastructural localization of serotonin1A receptors in the rat brain. J Neurosci Res 46: 697–708

    Article  PubMed  CAS  Google Scholar 

  • Kia HK, Miquel MC, Brisorgueil MJ, Daval G, Riad M, El Mestikawy, S, Hamon M, Vergé D (1996b) Immunocytochemical localization of 5-HT1A receptors in the rat central nervous system. J Comp Neurol 365: 289–305

    Article  PubMed  CAS  Google Scholar 

  • Kidd EJ, Haj-Dahmane S, Jolas T, Lanfumey L, Fattaccini CM, Guardiola-Lemaitre B, Gozlan H, Hamon M (1993) New methoxy-chroman derivatives, 4[N-(5- methoxy-chroman-3-yl)N-propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(±)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors. J Pharmacol Exp Ther 264: 863–872

    PubMed  CAS  Google Scholar 

  • Kleven M, Ybema C, Carilla E, Hamon M, Koek W (1995) Modification of behavioral effects of 8-hydroxy-2-(di-n-propylamino)tetralin following chronic ethanol consumption in the rat: evidence for the involvement of 5-HT1A receptors in ethanol dependence. Eur J Pharmacol 281: 219–228

    Article  PubMed  CAS  Google Scholar 

  • Kobilka BK, Frielle T, Collins S, Yang-Feng T, Kobilka TS, Francke U, Lefkowitz RJ, Caron MG (1987) An intron-less gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 329: 75–79

    Article  PubMed  CAS  Google Scholar 

  • Kung M-P, Zhuang Z-P, Frederick D, Kung HK (1994) In vivo binding of [123I]4-(2′- methoxy-phenyl)-l-[2′-(N-2″-pyridinyl)-p-iodobenzamido-]ethyl-piperazine, p- MPPI, to 5-HT1A receptors in rat brain. Synapse 18: 359–366

    Article  PubMed  CAS  Google Scholar 

  • Kung M-P, Frederick D, Mu M, Zhi-** Z, Kung HK (1995) 4-(2′-Methoxy-phenyl)- l-[2′-(n-2″-pyridinyl)-p-iodobenzamido]-ethyl-piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies. J Pharmacol Exp Ther 272: 429–437

    PubMed  CAS  Google Scholar 

  • Laaris N, Haj-Dahmane S, Hamon M, Lanfumey L (1995) Glucocorticoid receptor- mediated inhibition by corticosterone of 5-HT1A autoreceptor functioning in the rat dorsal raphe nucleus. Neuropharmacology 24: 1201–1210

    Article  Google Scholar 

  • Laaris N, Le Poul E, Laporte AM, Hamon M, Lanfumey L (1996) Effects of stress on the functional status of somatodendritic 5-HT1A autoreceptors in the rat dorsal raphe nucleus. Fundam Clin Pharmacol (in press)

    Google Scholar 

  • Lanfumey L, Gaymard C, Fattaccini CM, Laporte AM, Lesourd M, Mocaer E, Hamon M (1993a) [3H]S-20499: a new high affinity radioligand for the specific labelling of central 5-HT1A receptor. Eur J Neurosci Suppl 6: 238

    Google Scholar 

  • Lanfumey L, Haj-Dahmane S, Hamon M (1993b) Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100135 and SDZ 216-525. Eur J Pharmacol 249: 25–35

    Article  PubMed  CAS  Google Scholar 

  • Lanfumey L, Gaymard C, Laporte AM, Lima L, Mocaer E, Hamon M (1994) [3H]S- 14506: a novel high affinity radioligand for the specific labelling of 5-HT1A receptors. Neuropsychopharmacology 10: 93S

    Google Scholar 

  • Langlois M, Brémont B, Rousselle D, Gaudy F (1993) Structural analysis by the comparative molecular field analysis method of the affinity of β-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptors. Eur J Pharmacol 244: 77–87

    Article  PubMed  CAS  Google Scholar 

  • Langlois X, El Mestikawy S, Arpin M, Triller A, Hamon M, Darmon M (1996) Differential addressing of 5-HT1A and 5-HT1B receptors in transfected LLC-PK1 epithelial cells: a model of receptor targeting in neurons. Neuroscience 74: 297–302

    Article  PubMed  CAS  Google Scholar 

  • Laporte AM, Schechter LE, Bolaños FJ, Vergé D, Hamon M, Gozlan H (1991) [3H]5- Methyl-urapidil labels 5-HT1A receptors and α 1 adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies. Eur J Pharmacol 198: 59–67

    Article  PubMed  CAS  Google Scholar 

  • Laporte AM, Lima L, Gozlan H, Hamon M (1994) Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse. Eur J Pharmacol 271: 505–514

    Article  PubMed  CAS  Google Scholar 

  • Laporte AM, Fattaccini CM, Lombard MC, Chauveau J, Hamon M (1995) Effects of dorsal rhizotomy and selective lesion of serotonergic and noradrenergic systems on 5-HT1A, 5-HT1B and 5-HT3 receptors in the rat spinal cord. J Neural Transm 100: 207–223

    Article  CAS  Google Scholar 

  • Laporte AM, Doyen C, Nevo IT, Chauveau J, Hauw JJ, Hamon M (1996) Autoradiographic map** of serotonin 5-HT1A, 5-HT1D, 5-HT2A, and 5-HT3 receptors in the aged human spinal cord. J Chem Neuroanat 11: 67–75

    Article  PubMed  CAS  Google Scholar 

  • Lauder J, Krebs H (1978) Serotonin as a differentiation signal in early neurogenesis. Dev Neurosci 3: 15–30

    Article  Google Scholar 

  • Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L (1995) Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedebergs Arch Pharmacol 352: 141–148

    PubMed  Google Scholar 

  • Liau LM, Sleight AJ, Pitha J, Peroutka SJ (1991) Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist. Pharmacol Biochem Behav 38: 555–559

    Article  PubMed  CAS  Google Scholar 

  • Lucas JJ, Mellström B, Colado MI, Naranjo JR (1993) Molecular mechanisms of pain: serotonin1A receptor agonists trigger transactivation by c-fos of the prodynorphin gene in spinal cord neurons. Neuron 10: 599–611

    Article  PubMed  CAS  Google Scholar 

  • Lum JT, Piercey MF (1988) Electrophysiological evidence that spiperone is an antagonist of 5-HT1A receptors in the dorsal raphe nucleus. Eur J Pharmacol 149: 9–15

    Article  PubMed  CAS  Google Scholar 

  • Marcinkiewicz M, Vergé D, Gozlan H, Pichat L, Hamon M (1984) Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain. Brain Res 291: 159–163

    Article  PubMed  CAS  Google Scholar 

  • Martin P, Beninger RJ, Hamon M, Puech AJ (1990) Antidepressant-like action of 8- OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism. Behav Brain Res 38: 135–144

    Article  PubMed  CAS  Google Scholar 

  • Matsuda T, Somboonthum P, Suzuki M, Asano S, Baba A (1995) Antidepressant-like effect by postsynaptic 5-HT1A receptor activation in mice. Eur J Pharmacol 280: 235–238

    Article  PubMed  CAS  Google Scholar 

  • Matthiessen L, Kia HK, Daval G, Riad M, Hamon M, Vergé D (1993) Immunocytochemical localization of 5-HT1A receptors in the rat immature cerebellum. Neuroreport 4: 763–766

    Article  PubMed  CAS  Google Scholar 

  • Meller E, Goldstein M, Bohmaker K (1990) Receptor reserve for 5- hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Mol Pharmacol 37: 231–237

    PubMed  CAS  Google Scholar 

  • Middlemiss DN, Fozard JR (1983) 8-Hydroxy-2-(di-n-propylamino)tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 30: 151–153

    Article  Google Scholar 

  • Middlemiss DN, Tricklebank MD (1992) Centrally active 5-HT receptor agonists and antagonists. Neurosci Biobehav Rev 16: 75–82

    Article  PubMed  CAS  Google Scholar 

  • Millan MJ, Colpaert FC (1991) 5-Hydroxytryptamine(HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner. J Pharmacol Exp Ther 256: 983–992

    PubMed  CAS  Google Scholar 

  • Millan MJ, Bervoets K, Colpaert FC (1991) 5-Hydroxytryptamine(5-HT)1A receptors and the tail-flick response. I. 8-Hydroxy-2-(di-n-propylamino)tetralin HBr- induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor- mediated activity. J Pharmacol Exp Ther 256: 973–982

    PubMed  CAS  Google Scholar 

  • Minisclou C, Benavides J, Claustre Y (1995) Activation of 5-HT1A receptors inhibits carbachol-stimulated inositol 1,4,5-trisphosphate mass accumulation in the rodent hippocampus. Neurochem Res 20: 977–983

    Article  PubMed  CAS  Google Scholar 

  • Miquel MC, Doucet E, Boni C, El Mestikawy S, Matthiessen L, Daval G, Vergé D, Hamon M (1991) Central serotonin1A receptors: respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic map** in the rat brain. Neurochem Int 19: 453–465

    Article  CAS  Google Scholar 

  • Miquel MC, Kia HK, Boni C, Doucet E, Daval G, Matthiessen L, Hamon M, Vergé D (1994) Postnatal development and localization of 5-HT1A receptor mRNA in rat forebrain and cerebellum. Devl Brain Res 80: 149–157

    Article  CAS  Google Scholar 

  • Mokrosz MJ, Chojnacka-Wojcik E, Tatarczynska E, Klodzinska A, Filip M, Boksa J, Charakchieva-Minol S, Mokrosz JL (1994) 1-(2-methoxyphenyl)-4-(4- succinimido) butyl-piperazine (MM-77): a new, potent, postsynaptic antagonist of 5-HT1A receptors. Med Chem Res 4: 161–169

    CAS  Google Scholar 

  • Mundey MK, Fletcher A, Marsden CA (1996) Effects of 8-OH-DPAT and 5-HT1A antagonists WAY 100135 and WAY 100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing. Br J Pharmacol 117: 750–756

    Article  PubMed  CAS  Google Scholar 

  • Nelson DL, Herbet A, Bourgoin S, Glowinski J, Hamon M (1978) Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol 14: 983–995

    PubMed  CAS  Google Scholar 

  • Nevo I, Langlois X, Laporte AM, Kleven M, Koek W, Lima L, Maudhuit C, Martres MP, Hamon M (1995) Chronic alcoholization alters the expression of 5-HT1A and 5-HT1B receptor subtypes in rat brain. Eur J Pharmacol 281: 229–239

    Article  PubMed  CAS  Google Scholar 

  • Oksenberg D, Peroutka SJ (1988) Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers. Biochem Pharmacol 37: 3429–3433

    Article  PubMed  CAS  Google Scholar 

  • Oleskevich S (1995) Gαo1 decapeptide modulates the hippocampal 5-HT1A potassium current. J Neurophysiol 74: 2189–2193

    PubMed  CAS  Google Scholar 

  • Pazos A, Palacios JM (1985) Quantitative autoradiographic map** of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346: 205–230

    Article  PubMed  CAS  Google Scholar 

  • Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple 3H-5- hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem 36: 220–226

    Article  PubMed  CAS  Google Scholar 

  • Penington NJ, Kelly JS, Fow AP (1991) A study of the mechanism of Ca2+ current inhibition produced by serotonin in rat dorsal raphe neurons. J Neurosci 11: 3594–3609

    PubMed  CAS  Google Scholar 

  • Pike VW, McCarron JA, Lammerstma AA, Hume SP, Poole K, Grasby PM, Malizia A, Cliffe IA, Fletcher A, Bench CJ (1995) First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635. Eur J Pharmacol 283: R1- R3

    Article  PubMed  CAS  Google Scholar 

  • Pohl M, Ballet S, Collin E, Mauborgne A, Bourgoin S, Benoliel JJ, Hamon M, Cesselin F (1997) Enkephalinergic and dynorphinergic neurons in the spinal cord and dorsal root ganglia of the polyarthritic rat — in vivo release and cDNA hybridization studies. Brain Res 749: 18–28

    Article  PubMed  CAS  Google Scholar 

  • Pompeiano M, Palacios JM, Mengod G (1992) Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci 12: 440–453

    PubMed  CAS  Google Scholar 

  • Prehn JHM, Backhauβ C, Karkoutly C, Nuglisch J, Peruche B, Roßberg C, Krieglstein J (1991) Neuroprotective properties of 5-HT1A receptor agonists in rodent models of focal and global cerebral ischemia. Eur J Pharmacol 203: 213–222

    Article  PubMed  CAS  Google Scholar 

  • Prisco S, Gagnotto A, Talone D, De Blasi A, Mennini T, Esposito E (1993) Tertatolol, a new ß-blocker, is a serotonin (5-hydroxytryptamine1A) receptor antagonist in rat brain. J Pharmacol Exp Ther 265: 739–744

    PubMed  CAS  Google Scholar 

  • Radja F, Laporte AM, Daval G, Vergé D, Gozlan H, Hamon M (1991) Autoradiography of serotonin receptor subtypes in the central nervous system. Neurochem Int 18: 1–15

    Article  PubMed  CAS  Google Scholar 

  • Radja F, Daval G, Hamon M, Vergé D (1992) Pharmacological and physicochemical properties of pre- versus postsynaptic 5-hydroxytryptamine1A receptor binding sites in the rat brain: a quantitative autoradiographic study. J Neurochem 58: 1338–1346

    Article  PubMed  CAS  Google Scholar 

  • Raghupathi RK, Brousseau DA, McGonigle P (1996) Time-course of recovery of 5- HT1A receptors and changes in 5-HT1A receptor mRNA after irreversible inactivation with EEDQ. Mol Brain Res 38: 233–242

    Article  PubMed  CAS  Google Scholar 

  • Raymond JR (1991) Protein kinase C induces phosphorylation and desensitization of the human 5-HT1A receptor. J Biol Chem 266: 14747–14753

    PubMed  CAS  Google Scholar 

  • Raymond JR, Albers FJ, Middleton JP (1992) Functional expression of human 5-HT1A receptors and differential coupling to second messengers in CHO cells. Naunyn- Schmiedebergs Arch Pharmacol 346: 127–137

    Article  PubMed  CAS  Google Scholar 

  • Raymond JR, Olsen CL, Gettys TW (1993) Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein α-subunits and lack of coupling to Gsα Biochemistry 32: 11064–11073

    Article  PubMed  CAS  Google Scholar 

  • Riad M, El Mestikawy S, Vergé D, Gozlan H, Hamon M (1991) Visualization and quantification of central 5-HT1A receptors with specific antibodies. Neurochem Int 19: 413–423

    Article  CAS  Google Scholar 

  • Riad M, Emerit MB, Hamon M (1994) Neurotrophic effects of ipsapirone and other 5- HT1A receptor agonists on septal cholinergic neurons in culture. Devl Brain Res 82: 245–258

    Article  CAS  Google Scholar 

  • Riad M, Garcia S, Hamon M, Descarries L (1995) Somatodendritic localization of the serotonin 5-HT1A receptor in adult rat brain. Soc Neurosci 21: 1368 (539.1)

    Google Scholar 

  • Riad M, Jodoin N, Garcia S, Langlois X, Darmon M, Hamon M, Descarries L (1996) Axonal localization of the serotonin 5-HT1B receptor in brain. Soc Neurosci 22: 1329 (528.2)

    Google Scholar 

  • Ritter JM, Jones T (1995) PET: a symposium highlighting its clinical and pharmacological potential. Trends Pharmacol Sci 16: 117–119

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez-Manzo G, Fernàndez-Guasti A (1994) Reversal of sexual exhaustion by serotonergic and noradrenergic agents. Behav Brain Res 62: 127–134

    Article  PubMed  CAS  Google Scholar 

  • Routledge C, Hartley J, Gurling J, Ashworth-Preece M, Brown G, Dourish CT (1994) In vivo characterization of the putative 5-HT1A receptor antagonist SDZ 216,525 using two models of somatodendritic 5-HT1A receptor function. Neuropharmacology 33: 359–366

    Article  PubMed  CAS  Google Scholar 

  • Schechter LE, Bolaños FJ, Gozlan H, Lanfumey L, Haj-Dahmane S, Laporte AM, Fattaccini CM, Hamon M (1990) Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone — biochemical and electrophysiological studies. J Pharmacol Exp Ther 255: 1335–1347

    PubMed  CAS  Google Scholar 

  • Schoeffter P, Fozard JR, Stoll A, Siegl H, Seiler MP, Hoyer D (1993) SDZ 216-525, a selective and potent 5-HT1A receptor antagonist. Eur J Pharmacol — Mol Pharmacol Sect 244: 251–257

    Article  CAS  Google Scholar 

  • Schreiber R, Opitz K, Glaser T, De Vry J (1993) Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats: involvement of presynaptic 5-HT1A receptors. Psychopharmacology 112: 100–110

    Article  PubMed  CAS  Google Scholar 

  • Sharp T, Backus LI, Hjorth S, Bramwell SR, Grahame-Smith DG (1990) Further investigation on the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378. Eur J Pharmacol 176: 331–340

    Article  PubMed  CAS  Google Scholar 

  • Sharp T, McQuade R, Fozard JR, Hoyer D (1993) The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo. Br J Pharmacol 109: 699–702

    Article  PubMed  CAS  Google Scholar 

  • Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Hamon M (1990) Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur J Neurosci 2: 1144–1154

    Article  PubMed  Google Scholar 

  • Sprouse JS (1991) Inhibition of dorsal raphe cell firing by MDL 73005EF, a novel 5- HT1A receptor ligand. Eur J Pharmacol 201: 163–169

    Article  PubMed  CAS  Google Scholar 

  • Stahl SM, Gastpar M, Keppel Hesselink JM, Traber J eds (1992) Serotonin 1A receptors in depression and anxiety, Raven, New York

    Google Scholar 

  • Svensson L, Fahlke C, Hard E, Engel J A (1993) Involvement of the serotonergic system in ethanol intake in the rat. Alcohol 10: 219–224

    Article  PubMed  CAS  Google Scholar 

  • Thielen RJ, Fangon NB, Frazer A (1996) 4-(2′-Methoxyphenyl)-1-[2′-[N-(2″- pyridinyl)-p-iodobenzamido]ethyl]piperazine and 4-(2′-methoxyphenyl)-l-[2′-[N- 2″-pyridinyl)-p-fluorobenzamido]ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors. J Pharmacol Exp Ther 277: 661–670

    PubMed  CAS  Google Scholar 

  • Trulson ME, Preussler DW, Gailyn A, Howell A, Frederickson CJ (1982) Raphe unit activity in freely moving cats: effects of benzodiazepines. Neuropharmacology 21: 1045–1050

    Article  PubMed  CAS  Google Scholar 

  • Van den Hoof P, Galvan M (1991) Electrophysiology of the 5-HT1A ligand MDL 73005EF in the rat hippocampal slice. Eur J Pharmacol 196: 291–298

    Article  Google Scholar 

  • Varrault A, Le Nguyen D, McClue S, Harris B, Jouin P, Bockaert J (1994) 5- Hydroxytryptamine1A receptor synthetic peptides. Mechanisms of adenylyl cyclase inhibition. J Biol Chem 269: 16720–16725

    PubMed  CAS  Google Scholar 

  • Vergé D, Daval G, Patey A, Gozlan H, El Mestikawy S, Hamon M (1985) Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur J Pharmacol 113: 463–464

    Article  PubMed  Google Scholar 

  • Vergé D, Daval G, Marcinkiewicz M, Patey A, El Mestikawy S, Gozlan H, Hamon M (1986) Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci 6: 3474–3482

    PubMed  Google Scholar 

  • Wadenberg M-L (1996) Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci Biobehav Rev 20: 325–339

    Article  PubMed  CAS  Google Scholar 

  • Wadenberg ML, Ahlenius S (1991) Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy. J Neural Transm 83: 43–53

    Article  CAS  Google Scholar 

  • Weissmann-Nanopoulos D, Mach E, Magre J, Demassey Y, Pujol JF (1985) Evidence for the localization of 5-HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem Int 7: 1061–1072

    Article  PubMed  CAS  Google Scholar 

  • Whitaker-Azmitia PM (1991) Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol Rev 43: 553–561

    PubMed  CAS  Google Scholar 

  • Wieland S, Lucki I (1990) Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test. Psychopharmacology 101: 497–504

    Article  PubMed  CAS  Google Scholar 

  • Wilkinson LO, Dourish CT (1991) Serotonin and animal behavior. In: Peroutka SJ (ed) Serotonin receptor subtypes: basic and clinical aspects. Wiley-Liss, New York, pp 147–210

    Google Scholar 

  • Yocca FD, Hyslop DK, Smith DW, Maayani S (1987) BMY 7378, a buspirone analog with high affinity, selectivity and low intrinsic activity at the 5-HT1A receptor in rat and guinea pig hippocampal membranes. Eur J Pharmacol 137: 293–294

    Article  PubMed  CAS  Google Scholar 

  • Yocca FD, Iben L, Meller E (1992) Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampus membranes. Mol Pharmacol 41: 1066–1072

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hamon, M. (2000). The Main Features of Central 5-HT1A Receptors. In: Baumgarten, H.G., Göthert, M. (eds) Serotoninergic Neurons and 5-HT Receptors in the CNS. Handbook of Experimental Pharmacology, vol 129. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60921-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60921-3_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-66715-5

  • Online ISBN: 978-3-642-60921-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Navigation